Research & Development

In the realm of oncology, bladder cancer remains a formidable adversary, claiming over 16,000 lives annually in the United States alone, with metastatic urothelial carcinoma (mUC) presenting particularly grim prospects. Imagine a scenario where a patient, battling advanced stages of this disease,

Today, we’re diving into the fascinating intersection of biopharmaceutical innovation and oncology with Ivan Kairatov, a renowned expert in biopharma with extensive experience in research and development. Ivan’s deep knowledge of technology and innovation in the industry makes him the perfect

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, and a deep understanding of technology and innovation in the industry. Today, we’re diving into the groundbreaking world of AI-driven drug discovery, focusing on a

Alzheimer’s disease (AD), the leading cause of dementia worldwide, poses a formidable challenge with its prevalence expected to triple by 2050, placing immense emotional and economic burdens on aging populations across the globe. This neurodegenerative condition, characterized by progressive memory

What if a diagnostic tool could save lives by detecting prostate cancer just as effectively, but in half the time and at a fraction of the cost? This isn’t a distant dream but a reality unveiled through a groundbreaking clinical trial that’s turning heads in the medical community. Prostate cancer,

Imagine a disease so pervasive that it ranks as the third leading cause of cancer-related deaths worldwide, with a staggering 90% of primary liver cancer cases falling under its umbrella. Hepatocellular carcinoma (HCC) presents an immense challenge to global health systems, with rising incidence